Latest News

Cinemark on Tuesday became the latest major theater operator to toss its hat in the ring, after AMC Theatres and Regal Cinemas previously backed the $110 billion Paramount-Warner Bros. Discovery merge

Meta Platforms, Inc. stock is under pressure amid renewed AI bubble fears, and legal headwinds, yet the fundamental thesis is not broken, presenting a compelling risk-reward opportunity. META's aggres

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Intuit To Contact Him Directly To Discuss Their Options If you purchased or acquired

IBM (IBM) achieved a milestone by linking and cooling two cryogenic modules, advancing toward a fault-tolerant quantum computer. Target (TGT) delivered strong Q2 results, exceeding expectations on EPS

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In EquipmentShare To Contact Him Directly To Discuss Their Options If you purchased or a

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hub Group To Contact Him Directly To Discuss Their Options If you purchased or acquir

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis" or the "Company") (NAS

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Megan To Contact Him Directly To Discuss Their Options If you purchased or acquired s

ATI delivered strong, upbeat Q2 FY26 results with an over 10.6% increase in its revenue and strong margin expansion, underscoring ATI's progress and recovery in certain parts of the business. Strong b

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options If you purchased or acquir

BioMarin will acquire Alesta Therapeutics for $275 million upfront, and up to an additional $215 million based on milestones. Alesta Therapeutic's lead drug is a potential treatment for hypophosphatas

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Planet Fitness To Contact Him Directly To Discuss Their Options If you purchased or a

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rackspace To Contact Him Directly To Discuss Their Options If you purchased or acquir

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wix To Contact Him Directly To Discuss Their Options If you purchased or acquired sec

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ

Blue Owl Technology Finance Corp (OTF) delivered a strong Q2, with a 2.4% total NAV return and robust share repurchases boosting NAV accretion. OTF's 13.9% dividend yield will reset lower as special d

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wise To Contact Him Directly To Discuss Their Options If you purchased or acquired se

Marvell Technology Inc (NASDAQ:MRVL) issued Alphabet's Google a warrant to buy up to 58.97 million shares at $206.58 apiece, expanding a custom chip partnership between the two companies. The warrant

Eyepoint Pharmaceuticals (EYPT) plunged 70% after its LUGANO Phase 3 trial for Duravyu in wet AMD failed the primary endpoint due to an anomalous cohort. EYPT's management argues the failure was driv

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Wix.com Ltd. ("Wix" or the "Company") (NASDAQ: WIX) on